Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

June 30, 2008

Conditions
Retinal Disease
Interventions
DRUG

Avastin (Bevacizumab)

Intravitreal injection of 125 mg Avastin

Trial Locations (1)

16666

Siamak Moradian, MD, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT00370851 - Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial | Biotech Hunter | Biotech Hunter